site aa pred_sec pred_expbur pred_accessibility pdb_asym_id hetero nucleotide compound metal otherpoly homo precipitant A C D E F G H I K L M N P Q R S T V W Y feature_table variant 1 M 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 INIT_MET:/note="Removed":INIT_MET:/note="Removed":DISORDER:predicted by DISOPRED 2 T 17 0 6 0 0 2 0 0 0 3 0 12 2 0 0 34 22 2 0 0 MOD_RES:/note="N-acetylthreonine":MOD_RES:/note="N-acetylthreonine":DISORDER:predicted by DISOPRED 3 S e 142.2 1yhn_A RILP_HUMAN:Rab interacting lysosomal protein[65 aa] 6 0 3 4 1 7 0 2 7 1 0 8 9 2 0 43 7 0 0 1 DISORDER:predicted by DISOPRED 4 R e 41.9 1yhn_A 0 0 2 8 0 5 2 2 18 0 0 8 1 10 35 4 3 0 0 2 5 K e 62.3 1yhn_A 2 0 2 7 1 0 1 0 40 1 0 5 1 8 11 10 1 0 0 8 6 K e 66.0 1vg0_B 2 0 12 13 0 0 1 6 23 0 0 7 4 5 10 11 0 5 0 0 7 V e 54.0 1vg8_D 7 1 5 3 2 4 4 12 6 13 2 3 6 1 3 4 6 16 0 4 8 L E e 46.1 1vg8_D RILP_HUMAN:G0SGS3_CHATD:PDZD8_HUMAN:Rab interacting lysosomal protein[65 aa]:Mon1[155 aa]:Mon1[143 aa]:PDZ domain-containing protein 8[106 aa] 4 0 3 8 4 0 0 7 2 41 3 2 0 3 4 2 2 12 0 1 MUTAGEN:/note="L->A: Abolishes interaction with RILP and reduces its localization to late endosomal/lysosomal compartments.":MUTAGEN:/note="L->A: Abolishes interaction with RILP and reduces its localization to late endosomal/lysosomal compartments." 9 L E b 0.0 1vg8_D 2 1 0 0 28 0 1 18 0 20 10 0 0 0 2 1 0 12 0 5 10 K E b 16.5 1vg8_D RILP_HUMAN:G0SGS3_CHATD:PDZD8_HUMAN:Rab interacting lysosomal protein[65 aa]:Mon1[155 aa]:Mon1[143 aa]:PDZ domain-containing protein 8[106 aa] 0 0 0 3 0 0 2 0 79 0 0 1 0 1 13 1 1 0 0 0 MUTAGEN:/note="K->A: Abolishes interaction with RILP and localization to late endosomal/lysosomal compartments.":MUTAGEN:/note="K->A: Abolishes interaction with RILP and localization to late endosomal/lysosomal compartments." 11 V E b 0.0 1vg8_D 1 6 0 0 3 0 0 28 0 23 1 0 0 0 0 0 1 36 0 1 12 I E b 0.0 1vg8_D 11 2 0 0 0 3 0 14 0 18 3 0 0 0 0 1 4 44 0 0 13 I E b 1.2 1vg8_D 1 1 0 0 4 0 0 25 0 33 5 0 0 0 0 1 4 28 0 0 14 L E b 0.0 1vg8_D 6 3 0 0 1 0 0 22 0 30 5 1 0 0 1 0 1 31 0 0 15 G b 0.0 1vg8_D 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791":BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791" 16 D e 20.4 1vg8_D PDZD8_HUMAN:PDZ domain-containing protein 8[106 aa] GNP:GTP:GDP:2UK SO4 7 0 51 7 0 2 2 0 1 8 1 4 3 2 5 4 0 0 0 2 BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791":BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791" 17 S T e 36.7 1vg8_D RAE1_RAT:Rab proteins geranylgeranyltransferase component A.. GNP:GTP:GDP:2UK SO4 6 1 6 1 0 19 0 1 1 3 1 2 11 5 6 26 2 4 0 4 BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791":BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791" 18 G T e 41.7 1vg8_D GNP:GTP:GDP:2UK SO4 17 2 6 4 1 36 1 0 2 1 1 14 0 2 2 8 2 0 0 1 BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791":BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791" 19 V S b 0.0 1vg8_D GNP:GTP:GDP:2UK SO4 10 6 0 0 0 0 2 1 0 0 0 0 0 0 0 8 7 66 0 0 BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791":BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791" 20 G S b 14.3 1vg8_D GNP:GTP:GDP:2UK SO4 1 0 0 0 0 99 0 0 0 0 0 0 0 0 0 0 0 0 0 0 BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791":BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791" 21 K H b 5.7 1vg8_D GNP:GTP:GDP:2UK MG SO4 0 0 0 0 0 0 0 1 99 0 0 0 0 0 0 0 0 0 0 0 BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791":BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791" 22 T H e 26.6 1vg8_D GNP:GTP:GDP:2UK MG SO4 0 0 0 0 0 1 0 0 1 1 0 0 0 0 0 44 53 0 0 0 MUTAGEN:/note="T->N: Abolishes localization on late endosomes, lysosomes and phagosomes and reduces phagosomal fusions. Abolishes association of RILP with the phagosomes. No loss of interaction with CLN5. No loss of interaction with PRPH. Reduced interaction with VPS13A. Inhibits SARS-CoV-2 infection." ECO:0000269|PubMed:22431521, ECO:0000269|PubMed:23179371, ECO:0000269|PubMed:30709847, ECO:0000269|PubMed:34159616":BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791":MUTAGEN:/note="T->N: Abolishes localization on late endosomes, lysosomes and phagosomes and reduces phagosomal fusions. Abolishes association of RILP with the phagosomes. No loss of interaction with CLN5. No loss of interaction with PRPH. Reduced interaction with VPS13A. Inhibits SARS-CoV-2 infection." ECO:0000269|PubMed:22431521, ECO:0000269|PubMed:23179371, ECO:0000269|PubMed:30709847, ECO:0000269|PubMed:34159616":BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791" 23 S H e 27.3 1vg8_D GNP:GTP:GDP:2UK 20 15 0 1 1 0 0 0 1 0 0 3 0 2 1 38 17 1 0 0 24 L H b 1.1 1vg8_D 0 0 0 0 7 0 0 17 0 67 4 0 0 0 0 0 1 4 0 0 25 M H b 5.3 1vg8_D 7 1 0 0 1 0 0 12 0 43 6 0 0 0 1 0 10 17 1 0 26 N H e 21.8 1vg8_D 2 1 2 6 3 2 7 11 7 9 3 15 0 5 5 6 3 8 0 4 27 Q H b 11.2 1vg8_D 6 2 0 2 1 0 1 2 4 3 1 2 0 18 39 8 3 6 0 1 28 Y H b 2.2 1vg8_D 1 0 1 0 44 0 3 4 0 21 0 0 0 0 1 1 1 1 1 21 29 V H b 18.7 1vg8_D 14 6 1 0 1 3 1 7 3 16 4 1 0 2 3 6 17 16 0 0 30 N H e 46.7 1vg8_D G0SGS3_CHATD:Mon1[155 aa]:Mon1[143 aa] 2 2 11 8 1 11 4 0 9 3 1 6 0 8 5 8 16 0 0 4 31 K S e 67.9 1vg8_D 1 0 12 4 0 26 1 0 14 2 0 20 0 2 7 4 4 1 0 0 32 K e 56.1 1vg8_D G0SGS3_CHATD:Mon1[155 aa]:Mon1[143 aa] 7 1 4 17 0 3 6 4 10 1 1 2 2 10 13 8 9 2 0 1 K->E:LB/B:rs1154975: -; 33 F e 34.4 1vg8_D G0SGS3_CHATD:Mon1[155 aa]:Mon1[143 aa] GNP:GTP:GDP:2UK 3 0 2 1 65 2 0 4 1 2 0 0 1 0 1 1 2 5 1 9 34 S e 50.0 1vg8_D GTP:GDP:GNP:2UK 7 1 6 8 1 4 1 6 3 4 1 5 13 5 3 16 5 11 0 1 BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791":BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791" 35 N S e 77.0 1vg8_D G0SGS3_CHATD:Mon1[155 aa]:Mon1[143 aa] GNP:GTP:GDP:2UK 3 0 12 19 1 7 2 4 8 3 3 6 7 3 1 8 8 3 0 1 BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791":BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791" 36 Q S e 79.1 1vg8_D GTP 4 0 15 17 1 6 4 2 7 1 1 6 2 10 3 6 6 7 0 1 BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791":BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791" 37 Y e 59.6 1vg8_D G0SGS3_CHATD:G0SD94_CHATD:Mon1[155 aa]:Ccz1[166 aa]:Mon1[143 aa]:Ccz1[165 aa] GTP:GNP:2UK 1 2 0 5 4 0 7 3 1 3 2 0 3 3 1 6 7 4 1 47 BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791":MOTIF:/note="Effector region":BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791":MOTIF:/note="Effector region" 38 K e 61.8 1vg8_D RILP_HUMAN:PDZD8_HUMAN:Rab interacting lysosomal protein[65 aa]:PDZ domain-containing protein 8[106 aa] GNP:GTP SO4 5 0 13 16 1 3 2 10 14 4 1 2 3 5 3 4 5 9 0 1 BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791":MOTIF:/note="Effector region":BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791":MOTIF:/note="Effector region" 39 A b 11.6 1vg8_D GNP:GTP:2UK 19 2 0 2 0 5 2 1 2 5 2 2 35 3 2 12 4 1 1 1 BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791":MOTIF:/note="Effector region":BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791":MOTIF:/note="Effector region" 40 T e 21.4 1vg8_D G0SD94_CHATD:Ccz1[166 aa]:Ccz1[165 aa] GNP:GTP:2UK MG 1 0 0 3 0 5 0 2 1 1 0 4 3 1 0 5 71 2 1 0 BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791":MOTIF:/note="Effector region":BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791":MOTIF:/note="Effector region" 41 I e 57.3 1vg8_D RILP_HUMAN:G0SGS3_CHATD:G0SD94_CHATD:OSBL1_MOUSE:RUBIC_HUMAN:PDZD8_HUMAN:Rab interacting lysosomal protein[65 aa]:Mon1[155 aa]:Ccz1[166 aa]:Mon1[143 aa]:Oxysterol-binding protein-related protein 1[137 aa..:Run domain Beclin-1-interacting and cysteine-rich ..:PDZ domain-containing protein 8[106 aa] 3 0 1 2 1 1 1 42 1 8 0 2 0 2 0 2 8 24 0 1 MOTIF:/note="Effector region":MOTIF:/note="Effector region" 42 G S b 17.9 1vg8_D RAE1_RAT:OSBL1_MOUSE:RUBIC_HUMAN:PDZD8_HUMAN:Rab proteins geranylgeranyltransferase component A..:Oxysterol-binding protein-related protein 1[137 aa..:Run domain Beclin-1-interacting and cysteine-rich ..:PDZ domain-containing protein 8[106 aa] 6 0 1 7 8 53 1 1 1 2 0 0 4 2 2 3 8 1 0 1 MOTIF:/note="Effector region":MOTIF:/note="Effector region" 43 A E e 22.3 1vg8_D RAE1_RAT:RILP_HUMAN:OSBL1_MOUSE:RUBIC_HUMAN:PDZD8_HUMAN:Rab proteins geranylgeranyltransferase component A..:Rab interacting lysosomal protein[65 aa]:Oxysterol-binding protein-related protein 1[137 aa..:Run domain Beclin-1-interacting and cysteine-rich ..:PDZ domain-containing protein 8[106 aa] 9 3 6 16 5 4 0 9 1 4 0 3 2 4 7 3 1 21 0 0 MOTIF:/note="Effector region":MOTIF:/note="Effector region" 44 D E e 68.5 1vg8_D RAE1_RAT:RILP_HUMAN:OSBL1_MOUSE:RUBIC_HUMAN:PDZD8_HUMAN:Rab proteins geranylgeranyltransferase component A..:Rab interacting lysosomal protein[65 aa]:Oxysterol-binding protein-related protein 1[137 aa..:Run domain Beclin-1-interacting and cysteine-rich ..:PDZ domain-containing protein 8[106 aa] 4 1 43 11 0 1 3 2 2 2 0 14 0 0 4 4 5 1 0 2 MOTIF:/note="Effector region":MOTIF:/note="Effector region" 45 F E e 37.3 1vg8_D RAE1_RAT:RILP_HUMAN:G0SGS3_CHATD:PDZD8_HUMAN:Rab proteins geranylgeranyltransferase component A..:Rab interacting lysosomal protein[65 aa]:Mon1[155 aa]:Mon1[143 aa]:PDZ domain-containing protein 8[106 aa] 1 1 1 1 37 1 1 6 1 6 2 1 1 2 2 6 6 10 0 15 MOTIF:/note="Effector region":MOTIF:/note="Effector region" 46 L E e 32.6 1vg8_D 5 1 3 3 5 7 5 5 8 14 1 3 1 2 4 3 2 10 0 18 47 T E e 42.2 1vg8_D RILP_HUMAN:G0SGS3_CHATD:Rab interacting lysosomal protein[65 aa]:Mon1[155 aa]:Mon1[143 aa] 6 1 2 6 1 0 1 5 4 3 2 4 3 1 11 13 22 9 1 3 48 K E e 20.3 1vg8_D 5 0 1 5 1 2 2 2 35 4 0 1 3 6 18 3 4 3 1 2 49 E E e 53.3 1vg8_D G0SGS3_CHATD:Mon1[155 aa]:Mon1[143 aa] 4 0 5 21 1 1 6 4 6 3 1 5 2 8 4 7 16 5 0 1 50 V E b 16.7 1vg8_D 2 3 1 2 4 1 0 28 0 12 5 1 0 0 0 2 2 31 1 3 51 M E e 52.7 1vg8_D 3 2 3 12 3 2 5 5 2 5 6 5 3 6 3 6 14 10 0 4 52 V S b 4.0 1vg8_D 2 1 0 1 1 2 0 29 2 13 2 1 3 1 2 1 4 32 1 3 53 D S e 67.3 1vg8_D 1 0 46 14 1 8 1 0 4 1 0 11 2 2 4 3 3 0 0 0 54 D S e 93.2 1vg8_D 1 1 18 7 1 40 2 1 4 1 0 12 0 1 1 6 1 1 0 1 55 R e 49.0 1vg8_D 3 0 3 15 0 5 2 2 23 1 1 3 1 11 16 3 7 2 0 0 56 L E e 59.0 1vg8_D 3 1 5 7 1 5 1 4 8 9 1 3 8 6 7 7 15 7 0 1 57 V E b 1.3 1vg8_D 4 6 0 1 5 0 3 20 1 7 4 0 1 0 0 1 2 35 0 7 58 T E e 21.4 1vg8_D RILP_HUMAN:G0SGS3_CHATD:Rab interacting lysosomal protein[65 aa]:Mon1[155 aa]:Mon1[143 aa] 3 1 3 4 1 2 4 2 21 9 2 6 6 2 7 9 14 4 0 1 59 M E b 0.0 1vg8_D G0SGS3_CHATD:Mon1[143 aa] 3 1 0 1 10 0 0 10 0 59 3 0 0 0 0 0 2 8 0 1 60 Q E b 14.3 1vg8_D RILP_HUMAN:G0SGS3_CHATD:PDZD8_HUMAN:Rab interacting lysosomal protein[65 aa]:Mon1[155 aa]:Mon1[143 aa]:PDZ domain-containing protein 8[106 aa] 3 0 9 10 2 5 8 1 5 4 3 7 0 29 5 3 3 1 0 0 61 I E b 0.0 1vg8_D 1 1 0 0 5 0 0 44 0 26 2 0 0 0 0 0 1 18 0 0 62 W E b 11.2 1vg8_D RAE1_RAT:RILP_HUMAN:G0SGS3_CHATD:RUBIC_HUMAN:PDZD8_HUMAN:Rab proteins geranylgeranyltransferase component A..:Rab interacting lysosomal protein[65 aa]:Mon1[155 aa]:Mon1[143 aa]:Run domain Beclin-1-interacting and cysteine-rich ..:PDZ domain-containing protein 8[106 aa] 0 1 0 0 7 0 1 7 0 11 2 0 0 3 3 0 2 4 53 5 63 D E b 6.8 1vg8_D RAE1_RAT:Rab proteins geranylgeranyltransferase component A.. GTP MG 1 0 92 3 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791":BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791" 64 T E b 3.9 1vg8_D GNP:GTP:2UK MG 2 1 0 3 2 1 0 6 0 3 1 1 1 0 0 3 69 6 0 1 BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791":BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791" 65 A b 0.9 1vg8_D RAE1_RAT:Rab proteins geranylgeranyltransferase component A.. GTP:GNP 57 2 1 2 1 14 1 0 1 0 0 2 8 1 2 5 1 1 1 0 BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791":BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791" 66 G S b 15.5 1vg8_D PDZD8_HUMAN:PDZ domain-containing protein 8[106 aa] GNP:GTP:2UK 1 0 2 2 0 88 0 0 1 0 0 0 1 1 0 3 0 0 0 0 BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791":BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791" 67 Q S e 20.9 1vg8_D RAE1_RAT:G0SD94_CHATD:OSBL1_MOUSE:Rab proteins geranylgeranyltransferase component A..:Ccz1[166 aa]:Ccz1[165 aa]:Oxysterol-binding protein-related protein 1[137 aa.. 2 1 3 2 0 3 6 2 3 4 1 2 3 58 1 6 3 0 1 0 MUTAGEN:/note="Q->L: Does not abolish localization on late endosomes, lysosomes and phagosomes and does not reduce phagosomal fusions. No loss of interaction with CLN5 and VPS13A. Increases interaction with PRPH. Inhibits SARS-CoV- 2 infection." ECO:0000269|PubMed:22431521, ECO:0000269|PubMed:23179371, ECO:0000269|PubMed:30709847, ECO:0000269|PubMed:34159616":BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791":MUTAGEN:/note="Q->L: Does not abolish localization on late endosomes, lysosomes and phagosomes and does not reduce phagosomal fusions. No loss of interaction with CLN5 and VPS13A. Increases interaction with PRPH. Inhibits SARS-CoV- 2 infection." ECO:0000269|PubMed:22431521, ECO:0000269|PubMed:23179371, ECO:0000269|PubMed:30709847, ECO:0000269|PubMed:34159616":BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791" 68 E G e 81.4 1vg8_D G0SD94_CHATD:PDZD8_HUMAN:Ccz1[166 aa]:Ccz1[165 aa]:PDZ domain-containing protein 8[106 aa] GTP 4 1 15 52 1 2 2 1 2 1 0 2 6 3 3 3 1 1 0 1 69 R G e 73.9 1vg8_D RAE1_RAT:G0SD94_CHATD:OSBL1_MOUSE:PDZD8_HUMAN:Rab proteins geranylgeranyltransferase component A..:Ccz1[166 aa]:Ccz1[165 aa]:Oxysterol-binding protein-related protein 1[137 aa..:PDZ domain-containing protein 8[106 aa] 5 1 8 19 2 2 4 2 10 2 0 1 1 4 31 5 2 1 1 2 70 F G e 27.3 1vg8_D RAE1_RAT:RILP_HUMAN:OSBL1_MOUSE:PDZD8_HUMAN:Rab proteins geranylgeranyltransferase component A..:Rab interacting lysosomal protein[65 aa]:Oxysterol-binding protein-related protein 1[137 aa..:PDZ domain-containing protein 8[106 aa] 4 2 1 1 40 3 2 4 2 7 1 1 0 1 0 0 0 7 1 24 71 Q S e 37.8 1vg8_D RAE1_RAT:OSBL1_HUMAN:PDZD8_HUMAN:Rab proteins geranylgeranyltransferase component A..:Oxysterol-binding protein-related protein 1[135 aa..:PDZ domain-containing protein 8[106 aa] K PG4:P33 2 1 7 12 0 4 3 0 7 3 0 4 2 11 24 10 4 1 0 1 72 S e 33.6 1vg8_D RAE1_RAT:RILP_HUMAN:RUBIC_HUMAN:PDZD8_HUMAN:Rab proteins geranylgeranyltransferase component A..:Rab interacting lysosomal protein[65 aa]:Run domain Beclin-1-interacting and cysteine-rich ..:PDZ domain-containing protein 8[106 aa] 16 2 2 5 1 5 1 2 5 1 0 5 3 5 11 25 8 2 1 0 MOD_RES:/note="Phosphoserine" ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163":MOD_RES:/note="Phosphoserine" ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163" 73 L S e 99.4 1vg8_D RILP_HUMAN:G0SGS3_CHATD:OSBL1_MOUSE:RUBIC_HUMAN:PDZD8_HUMAN:Rab interacting lysosomal protein[65 aa]:Mon1[155 aa]:Mon1[143 aa]:Oxysterol-binding protein-related protein 1[137 aa..:Run domain Beclin-1-interacting and cysteine-rich ..:PDZ domain-containing protein 8[106 aa] 1 2 0 1 2 1 1 18 1 38 20 1 1 1 1 1 3 5 1 1 74 G e 60.7 1vg8_D RAE1_RAT:RUBIC_HUMAN:PDZD8_HUMAN:Rab proteins geranylgeranyltransferase component A..:Run domain Beclin-1-interacting and cysteine-rich ..:PDZ domain-containing protein 8[106 aa] 5 1 3 1 1 14 1 3 1 3 0 4 5 2 25 3 14 2 10 0 75 V e 24.0 1vg8_D RAE1_RAT:RUBIC_HUMAN:PDZD8_HUMAN:Rab proteins geranylgeranyltransferase component A..:Run domain Beclin-1-interacting and cysteine-rich ..:PDZ domain-containing protein 8[106 aa] 6 1 13 7 1 1 2 8 5 3 1 2 18 3 9 12 4 5 0 1 76 A G e 48.2 1vg8_D RAE1_RAT:RILP_HUMAN:G0SGS3_CHATD:RUBIC_HUMAN:PDZD8_HUMAN:Rab proteins geranylgeranyltransferase component A..:Rab interacting lysosomal protein[65 aa]:Mon1[155 aa]:Mon1[143 aa]:Run domain Beclin-1-interacting and cysteine-rich ..:PDZ domain-containing protein 8[106 aa] 17 1 1 5 1 2 8 3 5 15 4 1 1 8 6 17 3 3 1 0 77 F G b 14.4 1vg8_D RAE1_RAT:RILP_HUMAN:G0SGS3_CHATD:OSBL1_MOUSE:RUBIC_HUMAN:PDZD8_HUMAN:Rab proteins geranylgeranyltransferase component A..:Rab interacting lysosomal protein[65 aa]:Mon1[155 aa]:Mon1[143 aa]:Oxysterol-binding protein-related protein 1[137 aa..:Run domain Beclin-1-interacting and cysteine-rich ..:PDZ domain-containing protein 8[106 aa] 2 5 1 1 12 3 1 3 0 3 0 1 0 1 7 11 0 2 2 46 78 Y G b 5.7 1vg8_D PDZD8_HUMAN:PDZ domain-containing protein 8[106 aa] 3 4 1 0 6 2 1 12 0 6 7 0 0 0 0 6 3 1 2 46 79 R T e 58.1 1vg8_D RAE1_RAT:RILP_HUMAN:G0SGS3_CHATD:RUBIC_HUMAN:PDZD8_HUMAN:Rab proteins geranylgeranyltransferase component A..:Rab interacting lysosomal protein[65 aa]:Mon1[155 aa]:Mon1[143 aa]:Run domain Beclin-1-interacting and cysteine-rich ..:PDZ domain-containing protein 8[106 aa] 3 0 0 7 0 3 2 4 9 1 1 3 6 4 43 6 4 2 0 1 80 G T e 69.0 1vg8_D RILP_HUMAN:G0SGS3_CHATD:PDZD8_HUMAN:Rab interacting lysosomal protein[65 aa]:Mon1[155 aa]:Mon1[143 aa]:PDZ domain-containing protein 8[106 aa] 3 1 12 2 1 28 2 1 3 2 1 10 0 9 3 7 4 3 6 1 81 A b 4.5 1vg8_D PDZD8_HUMAN:PDZ domain-containing protein 8[106 aa] 46 2 0 0 1 11 0 2 0 1 0 0 1 1 1 10 13 10 0 0 82 D b 7.4 1vg8_D RILP_HUMAN:G0SGS3_CHATD:PDZD8_HUMAN:Rab interacting lysosomal protein[65 aa]:Mon1[155 aa]:Mon1[143 aa]:PDZ domain-containing protein 8[106 aa] 3 0 39 7 0 0 10 1 1 2 2 11 0 8 1 5 1 6 0 1 83 C E b 0.0 1vg8_D 21 11 0 0 1 35 1 6 0 5 1 0 0 0 4 0 1 12 0 1 84 C E b 0.0 1vg8_D 18 6 0 0 19 1 2 17 0 6 0 0 0 0 0 0 1 23 0 7 85 V E b 0.0 1vg8_D 1 2 0 0 2 2 0 30 0 32 5 0 0 0 0 0 1 26 0 0 86 L E b 0.0 1vg8_D 1 2 0 0 10 1 1 20 0 45 2 1 0 0 0 0 0 13 0 4 87 V E b 0.7 1vg8_D 3 12 0 0 1 1 0 5 0 5 9 0 0 0 0 1 2 62 0 1 88 F E b 0.0 1vg8_D 0 0 0 0 36 0 2 3 0 2 0 0 0 1 0 0 0 10 0 46 89 D E b 8.0 1vg8_D 5 0 59 1 0 1 0 1 0 0 0 4 0 0 0 29 0 1 0 0 90 V T b 0.0 1vg8_D 5 2 0 0 0 3 0 35 0 12 1 1 1 0 0 7 1 30 0 1 91 T T b 19.5 1vg8_D 7 2 11 3 0 2 3 3 1 1 1 6 0 2 0 11 45 5 0 0 92 A e 25.0 1vg8_D 5 2 22 3 0 1 1 1 5 1 1 20 0 2 7 23 3 2 0 0 93 P H e 22.5 1vg8_D 4 1 1 10 1 4 2 1 9 4 2 1 17 6 25 4 6 2 0 2 94 N H e 75.2 1vg8_D OSBL1_MOUSE:Oxysterol-binding protein-related protein 1[136 aa.. 6 0 14 16 0 4 1 3 12 1 0 6 1 11 4 14 3 3 1 0 95 T H b 10.4 1vg8_D 3 0 3 2 0 1 1 0 1 0 1 3 1 0 4 61 18 0 0 0 96 F H b 6.7 1vg8_D OSBL1_MOUSE:Oxysterol-binding protein-related protein 1[136 aa.. 1 1 0 2 57 0 0 3 1 12 1 0 0 1 3 2 2 3 0 10 97 K H e 67.0 1vg8_D OSBL1_MOUSE:Oxysterol-binding protein-related protein 1[136 aa.. 3 0 18 31 0 1 2 2 8 5 1 7 1 9 3 4 3 1 0 1 98 T T e 26.0 1vg8_D OSBL1_MOUSE:PDZD8_HUMAN:Oxysterol-binding protein-related protein 1[136 aa..:PDZ domain-containing protein 8[106 aa] P33 8 1 4 10 1 2 5 2 6 4 1 24 3 2 6 12 3 4 0 2 99 L H b 0.0 1vg8_D 7 3 1 0 1 0 1 22 1 25 4 0 0 0 0 3 3 27 0 0 100 D H e 35.2 1vg8_D 6 0 11 14 0 3 2 2 16 2 1 4 6 7 6 11 5 1 0 2 101 S H e 63.3 1vg8_D OSBL1_HUMAN:RUBIC_HUMAN:PDZD8_HUMAN:Oxysterol-binding protein-related protein 1[135 aa..:Run domain Beclin-1-interacting and cysteine-rich ..:PDZ domain-containing protein 8[106 aa] PG4:P33 6 0 4 8 2 3 4 5 15 4 2 9 3 6 8 11 7 2 0 2 102 W H b 8.0 1vg8_D OSBL1_HUMAN:PDZD8_HUMAN:Oxysterol-binding protein-related protein 1[135 aa..:PDZ domain-containing protein 8[106 aa] PG4:P33 5 1 0 3 5 1 0 4 2 14 1 0 0 1 0 2 0 2 52 5 103 R H b 7.1 1vg8_D OSBL1_HUMAN:Oxysterol-binding protein-related protein 1[135 aa.. 3 0 1 4 2 1 6 11 10 14 3 1 2 2 18 3 2 6 2 9 104 D H e 46.3 1vg8_D OSBL1_HUMAN:RUBIC_HUMAN:Oxysterol-binding protein-related protein 1[135 aa..:Run domain Beclin-1-interacting and cysteine-rich .. 4 0 13 20 1 3 2 3 11 2 1 6 7 8 5 6 4 2 0 1 105 E H e 31.2 1vg8_D OSBL1_HUMAN:RUBIC_HUMAN:PDZD8_HUMAN:Oxysterol-binding protein-related protein 1[135 aa..:Run domain Beclin-1-interacting and cysteine-rich ..:PDZ domain-containing protein 8[106 aa] PG4:P33 2 1 10 41 0 1 1 1 7 3 1 4 2 15 3 2 4 1 0 0 106 F H b 0.0 1vg8_D PDZD8_HUMAN:PDZ domain-containing protein 8[106 aa] 4 1 1 3 15 1 2 19 2 27 3 1 1 1 1 2 2 8 3 4 107 L H b 15.7 1vg8_D OSBL1_HUMAN:Oxysterol-binding protein-related protein 1[135 aa.. 4 2 4 4 3 1 4 13 5 27 2 2 1 5 8 3 2 6 1 2 108 I H e 67.3 1vg8_D RAE1_RAT:OSBL1_HUMAN:RUBIC_HUMAN:Rab proteins geranylgeranyltransferase component A..:Oxysterol-binding protein-related protein 1[135 aa..:Run domain Beclin-1-interacting and cysteine-rich .. 7 1 5 5 1 3 3 9 8 11 1 4 4 6 10 7 5 7 0 2 109 Q H e 30.1 1vg8_D RUBIC_HUMAN:PDZD8_HUMAN:Run domain Beclin-1-interacting and cysteine-rich ..:PDZ domain-containing protein 8[106 aa] 2 1 2 11 2 2 13 3 12 7 3 4 2 13 5 4 4 4 1 5 110 A H b 8.9 1vg8_D 22 4 4 3 4 4 2 4 4 13 0 3 2 2 6 6 5 10 1 2 111 S e 68.8 1vg8_D RAE1_RAT:OSBL1_HUMAN:RUBIC_HUMAN:Rab proteins geranylgeranyltransferase component A..:Oxysterol-binding protein-related protein 1[135 aa..:Run domain Beclin-1-interacting and cysteine-rich .. 7 3 6 5 2 7 4 2 7 5 1 6 3 2 15 14 6 3 0 2 112 P b 17.8 1vg8_D OSBL1_HUMAN:Oxysterol-binding protein-related protein 1[135 aa.. 8 2 4 6 2 7 5 3 5 5 1 3 18 3 3 8 6 9 1 2 113 R S e 48.2 1vg8_D RAE1_RAT:OSBL1_HUMAN:Rab proteins geranylgeranyltransferase component A..:Oxysterol-binding protein-related protein 1[135 aa.. 5 1 4 9 3 5 5 3 13 8 1 4 4 4 18 6 2 2 0 4 114 D S e 43.2 1vg8_D 5 3 20 9 2 10 3 3 2 7 1 8 3 4 4 5 5 6 0 2 115 P G e 38.0 1vg8_D OSBL1_HUMAN:Oxysterol-binding protein-related protein 1[135 aa.. 7 4 4 4 1 6 3 4 7 9 2 5 20 3 3 7 6 3 1 1 116 E G e 51.8 1vg8_D OSBL1_HUMAN:Oxysterol-binding protein-related protein 1[135 aa.. 7 1 14 20 1 3 3 2 8 3 1 3 4 7 4 8 4 4 0 2 117 N G e 59.4 1vg8_D 4 1 12 7 0 13 3 1 7 2 0 26 3 2 5 8 5 1 0 1 118 F S b 3.3 1vg8_D SO4 7 2 0 1 6 1 0 24 0 10 3 0 0 1 0 2 5 33 0 3 119 P b 14.0 1vg8_D 4 1 0 1 0 1 1 5 2 2 1 2 62 2 1 2 3 9 0 0 120 F E b 1.4 1vg8_D SO4 2 1 0 0 11 1 0 32 4 12 7 1 0 0 2 1 2 19 1 2 121 V E b 0.0 1vg8_D 4 1 0 0 1 1 0 26 0 20 11 0 0 0 0 0 4 30 0 1 122 V E b 0.7 1vg8_D 1 0 0 0 0 1 0 15 0 58 2 0 0 0 0 0 0 22 0 0 123 L E b 1.1 1vg8_D 4 4 0 0 3 0 0 13 0 16 1 0 0 0 0 0 2 54 0 0 124 G E b 0.0 1vg8_D 14 0 0 0 1 74 0 2 0 0 0 0 1 2 3 1 0 1 0 0 125 N E b 2.4 1vg8_D GNP:GTP:GDP:2UK 0 2 1 0 0 0 1 0 0 2 0 77 0 0 0 1 14 0 0 0 BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791":BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791" 126 K e 28.8 1vg8_D GNP:GTP:GDP:2UK 0 0 0 0 0 0 1 0 90 0 0 1 0 4 3 0 0 0 0 1 BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791":BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791" 127 I T e 27.5 1vg8_D 11 16 1 0 1 1 0 15 3 8 2 1 0 7 2 16 6 9 0 1 BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791":BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791" 128 D T e 23.5 1vg8_D GNP:GTP:GDP:2UK 2 0 92 1 0 0 1 0 0 0 0 0 0 1 0 2 1 0 0 0 BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791":BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791" 129 L S e 44.4 1vg8_D GTP:GDP:GNP 3 1 1 1 1 0 1 6 4 65 7 0 1 1 2 1 1 5 0 0 L->F:LP/P:rs1219090: Charcot-Marie-Tooth disease, axonal, 2B (CMT2B) ; 130 E S e 96.0 1vg8_D 7 1 11 23 0 3 3 1 6 3 1 3 6 5 13 8 4 3 0 1 131 N e 83.0 1vg8_D 4 0 19 8 1 6 8 1 8 1 1 16 1 4 4 12 5 1 0 1 132 R e 34.4 1vg8_D 2 0 4 10 0 3 2 1 10 2 1 2 1 4 44 4 2 2 0 3 133 Q e 63.8 1vg8_D 6 1 5 13 0 1 1 1 10 5 2 2 4 19 17 4 2 7 0 0 134 V S b 0.0 1vg8_D 6 0 2 5 1 2 0 12 2 4 0 1 1 4 1 1 3 54 0 0 135 A e 49.1 1vg8_D 6 1 12 2 1 5 0 4 4 4 0 1 7 4 1 22 9 16 0 1 136 T H e 42.9 1vg8_D 5 0 7 7 3 1 1 6 7 5 2 2 6 3 3 11 22 6 1 3 137 K H e 84.9 1vg8_D 7 0 8 27 1 1 2 2 15 1 0 6 2 7 6 8 3 1 0 2 138 R H e 38.3 1vg8_D OSBL1_MOUSE:Oxysterol-binding protein-related protein 1[136 aa.. 4 0 6 31 1 1 1 3 7 3 3 2 1 11 15 1 5 2 1 1 139 A H b 0.0 1vg8_D 33 0 3 11 0 22 1 6 1 5 2 1 1 3 1 3 3 4 0 1 140 Q H e 39.3 1vg8_D 7 1 3 15 1 11 2 1 13 5 1 3 1 21 11 2 1 1 0 1 141 A H e 54.5 1vg8_D OSBL1_MOUSE:Oxysterol-binding protein-related protein 1[136 aa.. 21 0 4 13 1 5 2 3 11 9 1 3 1 10 4 7 2 3 0 1 142 W H b 11.6 1vg8_D OSBL1_MOUSE:Oxysterol-binding protein-related protein 1[136 aa.. 6 1 1 5 12 2 1 2 5 21 4 1 1 4 2 3 2 5 14 8 143 C H b 0.0 1vg8_D 34 18 1 1 6 3 0 2 2 14 1 1 2 1 3 5 2 4 0 1 144 Y H e 67.8 1vg8_D 22 1 4 6 3 3 4 3 12 8 2 4 2 3 5 4 3 4 0 5 145 S H e 58.6 1vg8_D 8 0 11 14 0 5 2 0 10 2 1 3 1 7 9 17 5 3 0 0 146 K T b 17.9 1vg8_D 3 0 5 15 1 3 4 9 21 6 4 3 2 6 7 4 2 3 1 2 147 N T e 52.1 1vg8_D SO4 2 1 4 7 6 20 5 1 8 10 2 15 1 2 6 2 2 1 2 4 148 N S e 61.8 1vg8_D 11 1 5 5 3 24 1 2 5 1 0 21 0 2 7 7 2 1 0 0 149 I b 7.0 1vg8_D SO4 8 17 0 0 3 0 0 21 1 20 8 1 1 0 2 2 3 11 0 2 150 P e 34.1 1vg8_D SO4 7 3 2 3 3 6 3 3 11 7 3 1 22 6 3 9 5 2 0 2 151 Y E b 13.0 1vg8_D 1 3 0 0 44 0 3 3 0 7 1 0 0 0 0 0 0 3 3 31 152 F E b 17.2 1vg8_D 0 2 0 1 22 1 2 17 1 17 11 0 1 1 0 1 2 8 2 13 153 E E b 17.1 1vg8_D 2 0 3 77 2 1 1 0 1 0 1 1 1 2 2 3 1 1 0 1 154 T E b 0.0 1vg8_D 6 15 0 1 0 1 0 12 0 3 1 1 0 1 0 2 47 12 0 0 155 S B b 0.0 1vg8_D GNP:GTP:GDP:2UK 1 3 0 0 0 0 1 1 0 1 0 2 0 1 0 90 1 0 0 0 156 A T b 0.9 1vg8_D GNP:GTP:GDP:2UK 79 2 0 0 0 1 0 0 1 1 0 0 2 0 0 7 1 5 0 0 BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791":BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791" 157 K T e 41.0 1vg8_D GNP:GTP:GDP:2UK 5 0 0 1 1 0 0 1 65 12 2 0 0 1 5 2 5 1 0 0 BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791":BINDING:/ligand="GTP" /ligand_id="ChEBI:CHEBI:37565" ECO:0000269|PubMed:20028791" K->N:LP/P:rs1219090: Charcot-Marie-Tooth disease, axonal, 2B (CMT2B) ; 158 E T e 57.8 1vg8_D 4 1 11 19 1 0 1 1 3 8 1 7 0 6 0 9 24 1 0 4 159 A T e 48.2 1vg8_D 9 1 5 1 1 21 2 0 5 1 2 23 0 6 10 12 0 0 0 0 160 I B e 39.2 1vg8_D 2 1 6 11 5 0 5 14 4 8 3 1 1 9 2 5 10 4 2 7 161 N S e 35.8 1vg8_D 0 1 1 1 0 18 2 0 1 1 0 66 0 1 2 4 2 0 0 0 N->T:LP/P:rs1219090: Charcot-Marie-Tooth disease, axonal, 2B (CMT2B) ; 162 V H b 2.0 1vg8_D 1 0 0 1 3 0 0 20 1 9 1 0 0 0 0 0 2 60 0 1 V->M:LP/P:rs1219090: Charcot-Marie-Tooth disease, axonal, 2B (CMT2B) ; 163 E H e 31.2 1vg8_D 1 0 20 33 1 1 1 4 10 2 0 8 1 7 4 1 3 2 0 3 164 Q H e 44.9 1vg8_D 7 1 9 41 0 1 1 2 9 5 1 5 1 9 3 3 2 0 0 0 165 A H b 0.0 1vg8_D 32 2 1 0 1 1 0 7 1 16 3 0 8 0 0 4 3 21 0 0 166 F H b 0.5 1vg8_D 2 0 0 0 83 0 0 2 1 7 1 0 1 0 0 0 1 1 0 1 167 Q H e 57.1 1vg8_D 1 0 8 18 2 0 5 5 4 10 3 4 0 15 6 3 6 2 0 6 168 T H e 20.1 1vg8_D 6 3 6 18 2 3 3 2 5 4 3 3 0 3 4 5 16 3 5 4 169 I H b 0.0 1vg8_D 16 1 0 0 1 0 0 19 0 44 3 0 0 0 0 0 2 15 0 0 170 A H b 0.9 1vg8_D 37 3 0 3 1 1 0 13 0 7 1 0 0 1 1 4 7 21 0 0 171 R H e 35.6 1vg8_D 4 3 1 7 0 0 3 0 21 2 1 1 0 6 44 4 1 0 0 0 172 N H e 24.2 1vg8_D 8 2 8 17 1 0 5 4 12 5 0 7 0 7 4 7 5 6 0 0 173 A H b 0.0 1vg8_D 25 1 0 0 1 1 3 26 2 13 2 0 0 0 0 7 1 15 0 1 174 L H b 10.7 1vg8_D 1 1 0 2 4 0 0 10 7 47 4 1 4 1 9 2 1 6 0 2 175 K H e 75.9 1vg8_D 6 0 1 8 1 5 1 2 24 5 2 7 2 11 10 6 7 1 0 2 176 Q H b 19.4 1vg8_D 3 0 4 5 0 2 3 0 10 5 3 9 3 24 14 4 4 2 0 3 177 E H b 14.1 1vg8_D 1 0 6 21 2 2 4 2 13 2 3 4 6 9 14 7 1 2 0 2 178 T H e 33.8 1vg8_D RILP_HUMAN:Rab interacting lysosomal protein[65 aa] 7 2 4 5 0 11 1 2 9 2 5 5 5 4 9 12 14 2 0 0 179 E H e 29.1 1vg8_D 4 0 7 22 0 4 3 2 9 8 2 1 3 9 9 10 4 1 0 1 180 V H e 38.7 1vg8_D RILP_HUMAN:Rab interacting lysosomal protein[65 aa] 3 3 4 4 3 6 0 11 4 14 2 4 4 8 4 4 5 16 1 0 MUTAGEN:/note="V->A: Abolishes interaction with RILP and localization to late endosomal/lysosomal compartments.":MUTAGEN:/note="V->A: Abolishes interaction with RILP and localization to late endosomal/lysosomal compartments.":DISORDER:predicted by DISOPRED 181 E H e 41.2 1vg8_D RILP_HUMAN:Rab interacting lysosomal protein[65 aa] 8 0 11 23 1 1 6 1 6 4 2 4 4 14 3 6 3 3 0 0 DISORDER:predicted by DISOPRED 182 L H e 42.7 1vg8_D RILP_HUMAN:Rab interacting lysosomal protein[65 aa] 9 0 2 5 5 3 1 11 4 35 1 2 1 3 3 2 4 7 0 2 MUTAGEN:/note="L->A: Does not abolish interaction with RILP and localization to late endosomal/lysosomal compartments. Does not abolish interaction with RILP and localization to late endosomal/lysosomal compartments; when associated with A- 183.":MUTAGEN:/note="L->A: Does not abolish interaction with RILP and localization to late endosomal/lysosomal compartments. Does not abolish interaction with RILP and localization to late endosomal/lysosomal compartments; when associated with A- 183.":DISORDER:predicted by DISOPRED 183 Y H e 29.6 1vg8_D RILP_HUMAN:Rab interacting lysosomal protein[65 aa] 5 0 2 6 10 7 8 5 5 7 1 2 5 2 5 7 3 6 5 10 MUTAGEN:/note="Y->A: Does not abolish interaction with RILP and localization to late endosomal/lysosomal compartments. Does not abolish interaction with RILP and localization to late endosomal/lysosomal compartments; when associated with A- 182.":MUTAGEN:/note="Y->A: Does not abolish interaction with RILP and localization to late endosomal/lysosomal compartments. Does not abolish interaction with RILP and localization to late endosomal/lysosomal compartments; when associated with A- 182.":DISORDER:predicted by DISOPRED 184 N H e 76.4 1vg8_D 7 1 7 6 1 8 3 2 2 1 2 25 5 6 7 8 5 2 0 0 DISORDER:predicted by DISOPRED 185 E H e 61.3 1vg8_D RILP_HUMAN:Rab interacting lysosomal protein[65 aa] 4 0 9 25 0 5 3 4 10 5 1 5 2 11 3 5 2 4 0 1 DISORDER:predicted by DISOPRED 186 F S e 67.9 1vg8_D RAE1_RAT:Rab proteins geranylgeranyltransferase component A.. 10 0 6 2 14 6 0 5 4 13 2 4 2 3 5 12 4 4 0 2 DISORDER:predicted by DISOPRED 187 P e 59.7 1vg8_D 2 0 5 1 0 9 0 3 4 1 3 3 50 2 1 7 5 2 0 0 DISORDER:predicted by DISOPRED 188 E e 56.3 1vg8_D 4 0 16 20 0 3 1 2 7 7 0 5 5 10 3 9 3 2 0 0 DISORDER:predicted by DISOPRED 189 P e 98.4 1vg8_D RAE1_RAT:Rab proteins geranylgeranyltransferase component A.. 5 0 6 6 0 7 3 2 2 1 0 2 42 3 3 8 7 2 0 0 DISORDER:predicted by DISOPRED 190 I e 123.4 1vg8_D RAE1_RAT:Rab proteins geranylgeranyltransferase component A.. 2 0 2 2 0 7 0 30 2 11 4 1 4 2 2 6 4 20 0 0 DISORDER:predicted by DISOPRED 191 K e 77.8 1vg0_B RAE1_RAT:Rab proteins geranylgeranyltransferase component A.. 5 0 8 6 0 5 2 2 28 5 0 5 1 6 13 9 4 2 0 0 CROSSLNK:/note="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)":CROSSLNK:/note="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)":DISORDER:predicted by DISOPRED 192 L e 123.0 1vg0_B RAE1_RAT:Rab proteins geranylgeranyltransferase component A.. 0 0 1 2 4 0 0 13 6 38 5 0 6 2 4 6 1 11 0 0 DISORDER:predicted by DISOPRED 193 D 3 0 20 9 0 9 1 4 5 0 0 13 3 1 5 14 6 5 0 2 DISORDER:predicted by DISOPRED 194 K 3 2 2 3 3 3 1 5 29 7 0 6 5 3 5 13 6 2 0 2 CROSSLNK:/note="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)":CROSSLNK:/note="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)":DISORDER:predicted by DISOPRED 195 N 5 0 3 5 0 13 9 2 7 3 0 14 5 6 5 12 8 2 0 0 DISORDER:predicted by DISOPRED 196 D 6 0 27 6 0 3 1 0 2 3 0 12 9 8 6 7 7 0 1 0 DISORDER:predicted by DISOPRED 197 R 2 0 1 10 0 6 0 4 14 3 1 1 6 12 21 8 4 3 0 2 DISORDER:predicted by DISOPRED 198 A 21 0 0 4 0 7 5 3 11 3 3 1 8 6 3 16 4 4 0 0 DISORDER:predicted by DISOPRED 199 K 5 0 3 4 3 4 0 0 35 4 2 5 4 10 9 6 5 2 0 0 DISORDER:predicted by DISOPRED 200 A 15 2 3 2 0 11 2 0 8 2 0 5 8 4 6 19 9 2 0 0 DISORDER:predicted by DISOPRED 201 S 11 1 2 7 0 4 0 0 4 2 3 8 4 10 2 29 9 1 2 2 DISORDER:predicted by DISOPRED 202 A 17 4 2 5 5 16 0 2 11 4 0 2 3 3 0 13 3 9 0 0 DISORDER:predicted by DISOPRED 203 E 5 3 5 10 3 16 0 1 7 1 2 4 2 10 4 18 2 2 0 3 DISORDER:predicted by DISOPRED 204 S 5 11 0 3 0 19 3 0 7 0 0 6 1 2 3 33 4 2 0 0 DISORDER:predicted by DISOPRED 205 C 4 84 0 0 0 1 0 2 2 0 0 0 0 0 0 5 1 1 0 0 LIPID:/note="S-geranylgeranyl cysteine":LIPID:/note="S-geranylgeranyl cysteine":DISORDER:predicted by DISOPRED 206 S 10 4 0 4 0 11 5 2 2 0 0 3 2 3 0 44 3 3 0 3 DISORDER:predicted by DISOPRED 207 C 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MOD_RES:/note="Cysteine methyl ester":LIPID:/note="S-geranylgeranyl cysteine":MOD_RES:/note="Cysteine methyl ester":LIPID:/note="S-geranylgeranyl cysteine":DISORDER:predicted by DISOPRED